The Impact of Plasma Glucose Levels on In-Hospital and Long-Term Mortality in Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Patients

Basit Öğe Kaydı
dc.authoridTATLISU, Mustafa A/0000-0003-1058-7194
dc.authorwosidTATLISU, Mustafa A/H-5340-2018
dc.contributor.authorTatlisu, Mustafa Adem
dc.contributor.authorKaya, Adnan
dc.contributor.authorKeskin, Muhammed
dc.contributor.authorBaycan, Omer Faruk
dc.contributor.authorKayapinar, Osman
dc.contributor.authorCaliskan, Mustafa
dc.date.accessioned2021-12-01T18:49:27Z
dc.date.available2021-12-01T18:49:27Z
dc.date.issued2020
dc.department[Belirlenecek]en_US
dc.description.abstractObjective: Increased admission plasma glucose can be seen in the acute phase of acute coronary syndromes (ACS). Hence, we performed a retrospective study to evaluate the admission plasma glucose concentration in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) and who had no previous diagnosis of Diabetes Mellitus (DM). Methods: This retrospective study included 2504 consecutive confirmed STEMI patients treated with pPCI. The patients were divided into quantiles according to the admission glucose levels. Quantile I: 94 +/- 7 mg/dL (n = 626), quantile II: 112 +/- 5 mg/dL (n = 626), quantile III: 131 +/- 6 mg/dL (n = 626), quantile IV: 184 +/- 46 mg/dL (n = 626). Results: Patients with higher plasma glucose (Q4) had 6.6 times higher in-hospital all-cause mortality rates (95% CI: 3.95-9.30) and 3.12 times higher (95% CI: 2.2-4.4) long-term all-cause mortality rates than patients with lower plasma glucose (Q1-Q3), who had lower rates and were used as the reference. This significant relationship remained even after adjustment for all confounders. Conclusions: Even though glucose-lowering therapy is recommended in ACS patients with glucose levels >180 mg/dL, our results showed that high plasma glucose, even lower than 180 mg/dL, could predict in-hospital and long-term mortality.en_US
dc.identifier.endpage60en_US
dc.identifier.issn1309-3878
dc.identifier.issue1en_US
dc.identifier.startpage55en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/10723
dc.identifier.volume12en_US
dc.identifier.wosWOS:000518456300010en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherDuzce Univen_US
dc.relation.ispartofKonuralp Tıp Dergisi
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHyperglycemiaen_US
dc.subjectLong-Term Mortalityen_US
dc.subjectST-Segment Elevation Myocardial Infactionen_US
dc.subjectStress Hyperglycemiaen_US
dc.subjectAdmission Glucoseen_US
dc.subjectBlood-Glucoseen_US
dc.subjectDiseaseen_US
dc.subjectRisken_US
dc.titleThe Impact of Plasma Glucose Levels on In-Hospital and Long-Term Mortality in Non-Diabetic Patients with ST-Segment Elevation Myocardial Infarction Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
Ä°sim:
10723.pdf
Boyut:
522.42 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Ä°ndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Konuralp Tip Dergisi Koleksiyonu